Compounds > lissamine rhodamine b
Page last updated: 2024-08-24

lissamine rhodamine b and Adenocarcinoma

lissamine rhodamine b has been researched along with Adenocarcinoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
He, J; Huang, M; Huang, Y; Ren, D; Yi, C; Zhao, F; Zhu, H1
Abu-Dahab, R; Afifi, FU; Al-Kalaldeh, JZ1
Faessel, HM; Greco, WR; Levasseur, LM; Slocum, HK1
Aronne, T; Caliò, E; Franchi, F; Gargano, L; Pagani Guazzugli Bonaiuti, V; Sbaffi, E; Seminara, P1
Bokesch, H; Boyd, MR; Kenney, S; McMahon, J; Monks, A; Scudiero, D; Skehan, P; Storeng, R; Vistica, D; Warren, JT1

Other Studies

5 other study(ies) available for lissamine rhodamine b and Adenocarcinoma

ArticleYear
The synergistic effects of low dose fluorouracil and TRAIL on TRAIL-resistant human gastric adenocarcinoma AGS cells.
    BioMed research international, 2013, Volume: 2013

    Topics: Adenocarcinoma; Apoptosis; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; Fluorouracil; Gene Expression Regulation, Neoplastic; GPI-Linked Proteins; Humans; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor, Member 10c; Rhodamines; Stomach Neoplasms; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor Decoy Receptors

2013
Volatile oil composition and antiproliferative activity of Laurus nobilis, Origanum syriacum, Origanum vulgare, and Salvia triloba against human breast adenocarcinoma cells.
    Nutrition research (New York, N.Y.), 2010, Volume: 30, Issue:4

    Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Gas Chromatography-Mass Spectrometry; Humans; Jordan; Laurus; Magnoliopsida; Oils, Volatile; Origanum; Phytotherapy; Plant Extracts; Rhodamines; Salvia; Spices; Terpenes

2010
Parabolic growth patterns in 96-well plate cell growth experiments.
    In vitro cellular & developmental biology. Animal, 1999, Volume: 35, Issue:5

    Topics: Adenocarcinoma; Cecal Neoplasms; Cell Division; Colonic Neoplasms; Drug Screening Assays, Antitumor; Female; Humans; Ileal Neoplasms; Kinetics; Ovarian Neoplasms; Regression Analysis; Rhodamines; Sensitivity and Specificity; Staining and Labeling; Tumor Cells, Cultured

1999
In vitro models of a three-drug regimen (epirubicin, cisplatin and fluorouracil) for the treatment of colorectal cancer.
    Chemotherapy, 2001, Volume: 47, Issue:6

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cell Count; Cisplatin; Colonic Neoplasms; Drug Interactions; Drug Resistance, Neoplasm; Epirubicin; Fluorescent Dyes; Fluorouracil; Humans; Rhodamines; Tumor Cells, Cultured

2001
New colorimetric cytotoxicity assay for anticancer-drug screening.
    Journal of the National Cancer Institute, 1990, Jul-04, Volume: 82, Issue:13

    Topics: Adenocarcinoma; Calibration; Cell Count; Colonic Neoplasms; Colorimetry; Coloring Agents; Drug Screening Assays, Antitumor; Female; Humans; Hydrogen-Ion Concentration; Least-Squares Analysis; Microchemistry; Rhodamines; Trichloroacetic Acid; Tumor Cells, Cultured

1990